-
Patent Agency Ranking
公开(公告)号：KR101594980B1
公开(公告)日：2016-02-17
申请号：KR1020130131248
申请日：2013-10-31
Applicant: 서울대학교산학협력단 , 에스케이텔레콤 주식회사
IPC: G01N33/68 , G01N33/574 , G01N33/53 , C12Q1/68 , C12N15/11
Abstract: 본발명은췌장암의발병가능성여부의판단을위해사용될수 있는, 단백질또는이의유전자의발현수준을측정하는제제를포함하는췌장암진단용조성물, 키트, 이를사용한췌장암진단방법에관한것으로서, 본발명은췌장암의진단마커를제공함으로써, 췌장암의발병가능성, 조기진단및 질병정도를유의적으로예측또는파악할수 있으며, 췌장암의종양형성연구에활용될수 있다. 또한, 본발명의진단방법은비침습적으로혈액등으로부터간단하게췌장암을조기진단할수 있다.
-
公开(公告)号：KR1020130116433A
公开(公告)日：2013-10-24
申请号：KR1020120027653
申请日：2012-03-19
Applicant: 서울대학교산학협력단
CPC classification number: G01N33/6893 , C12Q1/6886 , C12Q2600/118 , G01N33/5302 , G01N2800/067
Abstract: PURPOSE: A marker for diagnosing pancreatic cancer is provided to early diagnose pancreatic cancer by combination according to specificity and sensitivity. CONSTITUTION: A marker for diagnosing pancreatic cancer is selected among alpha-1-anti chymotrypsin, alpha-1-antitrypsin, alpha-2-macroglobulin, ceruloplasmin, complement factor B, complement C4A, complement C4 gamma chain, complement C9, haptoglobin, hemopexin, kininogen, plasma protease C1 inhibitor, thyroxine binding globulin, transferrin, vitronectin, zinc alpha-2-glycoprotein, apolipoprotein A1, apolipoprotein A2, apolipoprotein A4, gelsolin, inter-alpha-trypsin inhibitor heavy chain H1, and pigment epithelium derived factor. Pancreatic cancer is diagnosed using a tissue, whole blood, plasma, or serum.
Abstract translation: 目的：根据特异性和敏感性，通过组合提供诊断胰腺癌的标志物，以早期诊断胰腺癌。 构成：用于诊断胰腺癌的标志物选自α-1-抗胰凝乳蛋白酶，α-1-抗胰蛋白酶，α-2-巨球蛋白，血浆铜蓝蛋白，补体因子B，补体C4A，补体C4γ链，补体C9，触珠蛋白，血红蛋白 ，激肽原，血浆蛋白酶C1抑制剂，甲状腺素结合球蛋白，转铁蛋白，玻连蛋白，α-2-糖蛋白，载脂蛋白A1，载脂蛋白A2，载脂蛋白A4，凝溶胶蛋白，α间胰蛋白酶抑制剂重链H1和色素上皮衍生因子。 使用组织，全血，血浆或血清诊断胰腺癌。
-
公开(公告)号：KR101837672B1
公开(公告)日：2018-03-12
申请号：KR1020157029860
申请日：2015-09-18
Applicant: 에스케이텔레콤 주식회사 , 서울대학교산학협력단
IPC: C12Q1/68 , G01N33/574
CPC classification number: G01N33/57438 , C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , G01N2333/4728
Abstract: 본발명은췌장암의발병가능성여부의판단을위해사용될수 있는, 단백질또는이의유전자의발현수준을측정하는제제를포함하는췌장암진단용조성물, 키트, 이를사용한췌장암진단방법에관한것으로서, 본발명은췌장암의진단마커를제공함으로써, 췌장암또는췌장암의전구병변의발병가능성, 조기진단및 질병정도를유의적으로예측또는파악할수 있으며, 췌장암의종양형성연구에활용될수 있다. 또한, 본발명의진단방법은비침습적으로혈액등으로부터간단하게췌장암을조기진단할수 있다.
-
公开(公告)号：KR1020160057352A
公开(公告)日：2016-05-23
申请号：KR1020157029860
申请日：2015-09-18
Applicant: 에스케이텔레콤 주식회사 , 서울대학교산학협력단
IPC: C12Q1/68 , G01N33/574
CPC classification number: G01N33/57438 , C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , G01N2333/4728
Abstract: 본발명은췌장암의발병가능성여부의판단을위해사용될수 있는, 단백질또는이의유전자의발현수준을측정하는제제를포함하는췌장암진단용조성물, 키트, 이를사용한췌장암진단방법에관한것으로서, 본발명은췌장암의진단마커를제공함으로써, 췌장암또는췌장암의전구병변의발병가능성, 조기진단및 질병정도를유의적으로예측또는파악할수 있으며, 췌장암의종양형성연구에활용될수 있다. 또한, 본발명의진단방법은비침습적으로혈액등으로부터간단하게췌장암을조기진단할수 있다.
-
公开(公告)号：KR1020100099934A
公开(公告)日：2010-09-15
申请号：KR1020090018515
申请日：2009-03-04
Applicant: 서울대학교산학협력단
Abstract: PURPOSE: A system and a method for processing medical knowledge are provided to efficiently and rapidly process medical knowledge by integrating a rule engine for processing medical rules with a guideline corresponding to an activity based process. CONSTITUTION: A model editor(210) inputs a medical knowledge model of an ontology language format, and a rule editor(220) edits a rule processed in a rule server. A rule storage unit(240) stores the edited rule and the medical knowledge model, and a rule manager(230) stores and searches the medical knowledge model and the rule at the rule storage place. A rule executor(250) processes the searched rule and the medical knowledge model.
Abstract translation: 目的：提供用于处理医学知识的系统和方法，以通过将用于处理医疗规则的规则引擎与对应于基于活动的过程的准则相结合来有效地和快速地处理医学知识。 构成：模型编辑器（210）输入本体语言格式的医学知识模型，并且规则编辑器（220）编辑规则服务器中处理的规则。 规则存储单元（240）存储编辑的规则和医学知识模型，并且规则管理器（230）在规则存储位置存储和搜索医学知识模型和规则。 规则执行者（250）处理所搜索的规则和医学知识模型。
-
-
-
-
Search Results
25
records
(took 0.025 seconds)
